Institutional Knowledge Map (KMap)
Map
Services
How To Use
About
Toggle theme
Loading...
Menu
Luz Badilla
Clinical Research Coordinator II
Medicine
Map Page
Research Area
dermatology,
immunology,
clinical trial,
drug efficacy,
safety,
clinical trials,
inflammatory diseases,
pharmacology,
psoriasis,
skin diseases
Grants
(3)
A Phase 3, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate Efficacy and Safety of Upadacitinib in Adult and Adolescent Subjects with Moderate to Severe Hidradenitis Suppurativa Who Have
Active
·
2024
·
$0 / $964K
·
External
clinical trials,
dermatology,
immunology,
inflammatory diseases,
pharmacology
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of PF-07275315 and PF-07264660 in Adult Participants With Moderate-Severe Atopic Dermatitis
Active
·
2024
·
$0 / $290.8K
·
External
dermatology,
clinical trial,
immunology,
drug efficacy,
safety
A Phase 4 Multicenter, Randomized, Double-Blind Study of Risankizumab for the Treatment of Adult Subjects with Moderate to Severe Genital Psoriasis or Moderate to Severe Scalp Psoriasis
Active
·
2023
·
$0 / $457.5K
·
External
dermatology,
psoriasis,
clinical trial,
immunology,
skin diseases
Collaborations
(3)
Kirsten Anderson
Mutual work: 3 Grants﹒3 Proposals
Collaboration Details
Gustavo Cornejo
Mutual work: 3 Proposals﹒3 Grants
Collaboration Details
Daniel Butler
Mutual work: 1 Supervisor
Collaboration Details
$0 / $1.7M Funding
